\-\ Texto\\:\\ \ \(0\)\
\-\ estropia\\ of\\ the\\ left\\ eye\\,\\ 6th\\ cranial\\ nerve\\ palsy\\ of\\ the\\ right\\ eye\\,\\ tongue\\ deviates\\ to\\ the\\ right\\ on\\ extension\\.\\ \\ hemoglobin\\ of\\ 9\\.7\\ hematocrit\\ of\\ 28\\.9\\ and\\ esr\\ of\\ 80\\.\\ otherwise\\ labs\\ are\\ within\\ normal\\ limits\\.\ \(0\)\
\-\ the\\ patient\\ is\\ undergoing\\ chemotherapy\\ according\\ to\\ cog\\ high\\ risk\\ renal\\ tumor\\ protocol\\.\ \(0\)\
\-\ \\â\\€\\¢\\ large\\ heterogenous\\ mass\\ of\\ the\\ right\\ kidney\\,\\ intraspinal\\ mass\\ at\\ t10\\,\\ bony\\ irregularity\\ of\\ c7\\,\\ t1\\,\\ and\\ t11\\.\ \(0\)\
\-\ \\â\\€\\¢\\ bone\\ marrow\\ of\\ the\\ calvarium\\,\\ skull\\ base\\,\\ and\\ clivus\\ are\\ infiltrated\\ with\\ abnormal\\ enhancing\\ soft\\ tissue\\ extending\\ into\\ the\\ epidural\\ spaces\\ and\\ right\\ cavernous\\ sinus\\.\ \(0\)\
\-\ \\â\\€\\¢\\ right\\ renal\\ mass\\ with\\ increased\\ uptake\\ also\\ noted\\ in\\ the\\ bilateral\\ calvarium\\,\\ skull\\ base\\,\\ clivus\\,\\ c1\\,\\ c2\\,\\ c7\\,\\ t1\\,\\ t11\\,\\ right\\ scapula\\,\\ proximal\\ right\\ humerus\\,\\ right\\ first\\ and\\ anterior\\ fifth\\ ribs\\,\\ left\\ acetabulum\\,\\ left\\ femur\\ and\\ right\\ tibia\\.\ \(0\)\
\-\ clear\\ cell\\ sarcoma\\ of\\ the\\ kidney\ \(0\)\
\-\ \\â\\€\\¢\\ clear\\ cell\\ sarcoma\\,\ \(0\)\
\-\ \\â\\€\\¢\\ malignant\\ rhabdoid\\ tumor\ \(0\)\
\-\ \\â\\€\\¢\\ rhabdomyosarcoma\ \(2\)\
\-\ \\â\\€\\¢\\ wilms\\ tumor\ \(0\)\
\-\ \\â\\€\\¢\\ pnet\ \(0\)\
\-\ \\â\\€\\¢\\ neuroblastoma\\.\ \(0\)\
\-\ 10\\ year\\ old\\ boy\\ with\\ dysphagia\\,\\ weight\\ loss\\,\\ slurred\\ speech\\ and\\ double\\ vision\\.\\ \\ there\\ is\\ no\\ significant\\ past\\ medical\\ history\\.\ \(0\)\
\-\ clear\\ cell\\ sarcoma\\ of\\ the\\ kidney\\ is\\ a\\ neoplasm\\ of\\ childhood\\ with\\ a\\ propensity\\ to\\ metastasize\\ to\\ bone\\.\\ \\ in\\ fact\\,\\ it\\ was\\ previously\\ called\\ bone\\ metastasizing\\ renal\\ tumor\\ of\\ childhood\\.\\ \\ it\\ less\\ frequently\\ metastasizes\\ to\\ lung\\,\\ abdomen\\,\\ retroperitoneum\\,\\ brain\\,\\ and\\ liver\\.\\ as\\ a\\ result\\,\\ both\\ conventional\\ radiographic\\ and\\ scintigraphic\\ skeletal\\ survey\\ are\\ recommended\\.\\ \\ it\\ represents\\ 3\\%\\ of\\ pediatric\\ renal\\ tumors\\ and\\ has\\ a\\ slight\\ male\\ predominance\\.\\ \\ \ \(0\)\
\-\ the\\ usual\\ presentation\\ is\\ abdominal\\ mass\\ noted\\ by\\ a\\ caregiver\\.\\ \\ physical\\ findings\\ typically\\ include\\ a\\ palpable\\ unilateral\\ abdominal\\ mass\\.\\ \\ hypertension\\ and\\ hematuria\\ are\\ also\\ associated\\ findings\\.\ \(0\)\
\-\ the\\ origin\\ of\\ clear\\ cell\\ sarcoma\\ has\\ not\\ been\\ established\\,\\ however\\,\\ the\\ cell\\ of\\ origin\\ has\\ been\\ suggested\\ to\\ be\\ renal\\ mesenchymal\\ with\\ neural\\ markers\\.\\ \\ \ \(0\)\
\-\ the\\ imaging\\ findings\\ typically\\ demonstrate\\ a\\ large\\ unicentric\\ mass\\ that\\ markedly\\ distorts\\ or\\ replaces\\ the\\ kidney\\.\\ \\ cystic\\ foci\\ are\\ typically\\ present\\ as\\ well\\ as\\ foci\\ of\\ necrosis\\ and\\ hemorrhage\\.\\ \\ as\\ previously\\ stated\\,\\ there\\ is\\ a\\ propensity\\ for\\ the\\ tumor\\ to\\ metastasize\\ to\\ bone\\ as\\ in\\ this\\ case\\.\ \(0\)\
\-\ at\\ presentation\\,\\ radical\\ nephrectomy\\ is\\ the\\ initial\\ treatment\\ of\\ choice\\ if\\ the\\ tumor\\ is\\ resectable\\,\\ along\\ with\\ chemotherapy\\ and\\ radiatio\\.\\ \\ if\\ the\\ lesion\\ is\\ not\\ resectable\\ then\\ chemotherapy\\ is\\ administered\\ and\\ an\\ attempt\\ at\\ resection\\ may\\ be\\ made\\ if\\ the\\ tumor\\ responds\\ to\\ therapy\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ the\\:\\ 0\\.21453579707159742\ \(0\)\
\-\ tumor\\:\\ 0\\.1968320904708195\ \(0\)\
\-\ sarcoma\\:\\ 0\\.18038627452970335\ \(0\)\
\-\ of\\:\\ 0\\.17884546172520502\ \(0\)\
\-\ renal\\:\\ 0\\.16738501569283618\ \(0\)\
\-\ right\\:\\ 0\\.1604088202343976\ \(0\)\
\-\ clear\\:\\ 0\\.1558935653833789\ \(0\)\
\-\ and\\:\\ 0\\.15551980917315322\ \(0\)\
\-\ cell\\:\\ 0\\.153761997563751\ \(0\)\
\-\ kidney\\:\\ 0\\.15106955162264749\ \(0\)\
\-\ propensity\\:\\ 0\\.14581422183738565\ \(0\)\
\-\ resectable\\:\\ 0\\.13981192985466623\ \(0\)\
\-\ is\\:\\ 0\\.1324994357912917\ \(0\)\
\-\ metastasize\\:\\ 0\\.13160695087744934\ \(0\)\
\-\ calvarium\\:\\ 0\\.12674732624614096\ \(0\)\
\-\ clivus\\:\\ 0\\.12674732624614096\ \(0\)\
\-\ mass\\:\\ 0\\.12320611472185342\ \(0\)\
\-\ t11\\:\\ 0\\.12220184620078599\ \(0\)\
\-\ to\\:\\ 0\\.12095591347001908\ \(0\)\
\-\ bone\\:\\ 0\\.11732948426784269\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.11451650072336315\ \(0\)\
\-\ typically\\:\\ 0\\.11321738896604436\ \(0\)\
\-\ childhood\\:\\ 0\\.10880363673577381\ \(0\)\
\-\ as\\:\\ 0\\.10798370003238258\ \(0\)\
\-\ c7\\:\\ 0\\.10604041943984213\ \(0\)\
\-\ are\\:\\ 0\\.10199473054800394\ \(0\)\
\-\ if\\:\\ 0\\.09370525830419774\ \(0\)\
\-\ origin\\:\\ 0\\.09255224207686333\ \(0\)\
\-\ foci\\:\\ 0\\.08787756189213494\ \(0\)\
\-\ skull\\:\\ 0\\.08723494605377656\ \(0\)\
\-\ previously\\:\\ 0\\.0863103238904091\ \(0\)\
\-\ eye\\:\\ 0\\.08601192865286227\ \(0\)\
\-\ estropia\\:\\ 0\\.08597171452721807\ \(0\)\
\-\ unicentric\\:\\ 0\\.08597171452721807\ \(0\)\
\-\ radiatio\\:\\ 0\\.08597171452721807\ \(0\)\
\-\ it\\:\\ 0\\.08255483734539876\ \(0\)\
\-\ metastasizes\\:\\ 0\\.08215056292833128\ \(0\)\
\-\ caregiver\\:\\ 0\\.08215056292833128\ \(0\)\
\-\ distorts\\:\\ 0\\.08215056292833128\ \(0\)\
\-\ base\\:\\ 0\\.08178633965293872\ \(0\)\
\-\ findings\\:\\ 0\\.07959608522312435\ \(0\)\
\-\ cog\\:\\ 0\\.07943941272295545\ \(0\)\
\-\ deviates\\:\\ 0\\.07733648124787991\ \(0\)\
\-\ metastasizing\\:\\ 0\\.07733648124787991\ \(0\)\
\-\ presentation\\:\\ 0\\.07401305442118386\ \(0\)\
\-\ has\\:\\ 0\\.07366609469395838\ \(0\)\
\-\ replaces\\:\\ 0\\.07290711091869283\ \(0\)\
\-\ responds\\:\\ 0\\.07080417944361728\ \(0\)\
\-\ infiltrated\\:\\ 0\\.06990596492733311\ \(0\)\
\-\ t1\\:\\ 0\\.0669899419197402\ \(0\)\
\-\ slurred\\:\\ 0\\.06698302784473048\ \(0\)\
\-\ retroperitoneum\\:\\ 0\\.06698302784473048\ \(0\)\
\-\ intraspinal\\:\\ 0\\.06526480772091925\ \(0\)\
\-\ t10\\:\\ 0\\.06337366312307048\ \(0\)\
\-\ rhabdoid\\:\\ 0\\.06337366312307048\ \(0\)\
\-\ with\\:\\ 0\\.06315964300445975\ \(0\)\
\-\ mesenchymal\\:\\ 0\\.06295474440423571\ \(0\)\
\-\ been\\:\\ 0\\.06264074566411527\ \(0\)\
\-\ markers\\:\\ 0\\.0621689461642791\ \(0\)\
\-\ scapula\\:\\ 0\\.061799325479839934\ \(0\)\
\-\ 6th\\:\\ 0\\.061100923100392994\ \(0\)\
\-\ scintigraphic\\:\\ 0\\.061100923100392994\ \(0\)\
\-\ at\\:\\ 0\\.060915918334431794\ \(0\)\
\-\ c1\\:\\ 0\\.06014171083446927\ \(0\)\
\-\ predominance\\:\\ 0\\.05955251152418369\ \(0\)\
\-\ radical\\:\\ 0\\.05955251152418369\ \(0\)\
\-\ acetabulum\\:\\ 0\\.05899799162531745\ \(0\)\
\-\ wilms\\:\\ 0\\.05899799162531745\ \(0\)\
\-\ abdominal\\:\\ 0\\.058804015468381585\ \(0\)\
\-\ survey\\:\\ 0\\.05873250591665662\ \(0\)\
\-\ tongue\\:\\ 0\\.057978173880953145\ \(0\)\
\-\ established\\:\\ 0\\.057978173880953145\ \(0\)\
\-\ pnet\\:\\ 0\\.05773957583509202\ \(0\)\
\-\ noted\\:\\ 0\\.05700546853718332\ \(0\)\
\-\ hemoglobin\\:\\ 0\\.056841361318807855\ \(0\)\
\-\ usual\\:\\ 0\\.055827037086355794\ \(0\)\
\-\ hematocrit\\:\\ 0\\.055636644360016474\ \(0\)\
\-\ administered\\:\\ 0\\.055636644360016474\ \(0\)\
\-\ c2\\:\\ 0\\.05545002203557525\ \(0\)\
\-\ speech\\:\\ 0\\.05545002203557525\ \(0\)\
\-\ attempt\\:\\ 0\\.05545002203557525\ \(0\)\
\-\ left\\:\\ 0\\.0550146991063886\ \(0\)\
\-\ conventional\\:\\ 0\\.054911354317769834\ \(0\)\
\-\ nephrectomy\\:\\ 0\\.054911354317769834\ \(0\)\
\-\ rhabdomyosarcoma\\:\\ 0\\.054401818367886906\ \(0\)\
\-\ according\\:\\ 0\\.05407681652630135\ \(0\)\
\-\ large\\:\\ 0\\.05387146050748546\ \(0\)\
\-\ palsy\\:\\ 0\\.053762650120710936\ \(0\)\
\-\ fifth\\:\\ 0\\.053458619902619416\ \(0\)\
\-\ stated\\:\\ 0\\.05316409220050176\ \(0\)\
\-\ ribs\\:\\ 0\\.052738871830199416\ \(0\)\
\-\ protocol\\:\\ 0\\.05246568982105482\ \(0\)\
\-\ irregularity\\:\\ 0\\.052070214197439645\ \(0\)\
\-\ fact\\:\\ 0\\.051567475304770655\ \(0\)\
\-\ choice\\:\\ 0\\.050974567901020514\ \(0\)\
\-\ humerus\\:\\ 0\\.05074746969724358\ \(0\)\
\-\ heterogenous\\:\\ 0\\.050635940355123865\ \(0\)\
\-\ also\\:\\ 0\\.05057301530353265\ \(0\)\
\-\ suggested\\:\\ 0\\.05030905951454522\ \(0\)\
\-\ called\\:\\ 0\\.050202571156455086\ \(0\)\
\-\ neural\\:\\ 0\\.04978825743131986\ \(0\)\
\-\ neuroblastoma\\:\\ 0\\.04939139376448565\ \(0\)\
\-\ esr\\:\\ 0\\.04919905812103428\ \(0\)\
\-\ unilateral\\:\\ 0\\.04919905812103428\ \(0\)\
\-\ spaces\\:\\ 0\\.04891772023131263\ \(0\)\
\-\ undergoing\\:\\ 0\\.04882577687355876\ \(0\)\
\-\ epidural\\:\\ 0\\.04882577687355876\ \(0\)\
\-\ skeletal\\:\\ 0\\.048734721871314675\ \(0\)\
\-\ dysphagia\\:\\ 0\\.04855520940720208\ \(0\)\
\-\ pediatric\\:\\ 0\\.04812084130881128\ \(0\)\
\-\ represents\\:\\ 0\\.04803631949186774\ \(0\)\
\-\ hematuria\\:\\ 0\\.04754451472203872\ \(0\)\
\-\ markedly\\:\\ 0\\.047464985816162215\ \(0\)\
\-\ double\\:\\ 0\\.0473861224319426\ \(0\)\
\-\ slight\\:\\ 0\\.047077107225944013\ \(0\)\
\-\ cavernous\\:\\ 0\\.04663179039623914\ \(0\)\
\-\ vision\\:\\ 0\\.04655957456839535\ \(0\)\
\-\ tibia\\:\\ 0\\.04593338801679219\ \(0\)\
\-\ marrow\\:\\ 0\\.044674972226566766\ \(0\)\
\-\ frequently\\:\\ 0\\.044271431459610745\ \(0\)\
\-\ femur\\:\\ 0\\.04410363855086124\ \(0\)\
\-\ cranial\\:\\ 0\\.04393878094606747\ \(0\)\
\-\ be\\:\\ 0\\.04361543473140968\ \(0\)\
\-\ there\\:\\ 0\\.04278076510300965\ \(0\)\
\-\ recommended\\:\\ 0\\.04276243347783054\ \(0\)\
\-\ limits\\:\\ 0\\.04247826764527639\ \(0\)\
\-\ not\\:\\ 0\\.04244523785506448\ \(0\)\
\-\ made\\:\\ 0\\.041462039357980277\ \(0\)\
\-\ bony\\:\\ 0\\.04142024718563933\ \(0\)\
\-\ uptake\\:\\ 0\\.04133721475936165\ \(0\)\
\-\ hypertension\\:\\ 0\\.041132778989698394\ \(0\)\
\-\ necrosis\\:\\ 0\\.0410924186735411\ \(0\)\
\-\ result\\:\\ 0\\.04024560189737969\ \(0\)\
\-\ in\\:\\ 0\\.04012018957147598\ \(0\)\
\-\ radiographic\\:\\ 0\\.03988448034421123\ \(0\)\
\-\ tumors\\:\\ 0\\.03953668739256103\ \(0\)\
\-\ sinus\\:\\ 0\\.038845604717884855\ \(0\)\
\-\ risk\\:\\ 0\\.03841152248907135\ \(0\)\
\-\ nerve\\:\\ 0\\.03835111126029157\ \(0\)\
\-\ otherwise\\:\\ 0\\.0383210502478217\ \(0\)\
\-\ malignant\\:\\ 0\\.0383210502478217\ \(0\)\
\-\ extension\\:\\ 0\\.038054730878280284\ \(0\)\
\-\ then\\:\\ 0\\.038054730878280284\ \(0\)\
\-\ palpable\\:\\ 0\\.03776738790566187\ \(0\)\
\-\ weight\\:\\ 0\\.03748854746379334\ \(0\)\
\-\ labs\\:\\ 0\\.03724445590601997\ \(0\)\
\-\ liver\\:\\ 0\\.03708517122262566\ \(0\)\
\-\ boy\\:\\ 0\\.03677445782409727\ \(0\)\
\-\ neoplasm\\:\\ 0\\.03669835415815438\ \(0\)\
\-\ less\\:\\ 0\\.03657286469520738\ \(0\)\
\-\ extending\\:\\ 0\\.0364490242874328\ \(0\)\
\-\ first\\:\\ 0\\.03627833699308972\ \(0\)\
\-\ initial\\:\\ 0\\.03606332874532445\ \(0\)\
\-\ along\\:\\ 0\\.03601620805006317\ \(0\)\
\-\ hemorrhage\\:\\ 0\\.03599273576042334\ \(0\)\
\-\ past\\:\\ 0\\.034992775376840354\ \(0\)\
\-\ resection\\:\\ 0\\.03445996587978589\ \(0\)\
\-\ medical\\:\\ 0\\.03416574470792305\ \(0\)\
\-\ enhancing\\:\\ 0\\.033676558840269724\ \(0\)\
\-\ proximal\\:\\ 0\\.033585327542918056\ \(0\)\
\-\ brain\\:\\ 0\\.033512973103679594\ \(0\)\
\-\ abdomen\\:\\ 0\\.03280170854205513\ \(0\)\
\-\ loss\\:\\ 0\\.03275171309632059\ \(0\)\
\-\ lung\\:\\ 0\\.03270198148002347\ \(0\)\
\-\ cystic\\:\\ 0\\.032376979638437914\ \(0\)\
\-\ abnormal\\:\\ 0\\.03229745073256141\ \(0\)\
\-\ include\\:\\ 0\\.03198588121853292\ \(0\)\
\-\ however\\:\\ 0\\.031818809456028954\ \(0\)\
\-\ 10\\:\\ 0\\.03143530254203622\ \(0\)\
\-\ significant\\:\\ 0\\.031039034942335984\ \(0\)\
\-\ therapy\\:\\ 0\\.030887805856791652\ \(0\)\
\-\ high\\:\\ 0\\.03055286941836303\ \(0\)\
\-\ anterior\\:\\ 0\\.03001566427826189\ \(0\)\
\-\ both\\:\\ 0\\.029978439268366925\ \(0\)\
\-\ physical\\:\\ 0\\.029149150337726422\ \(0\)\
\-\ increased\\:\\ 0\\.029070097943781303\ \(0\)\
\-\ bilateral\\:\\ 0\\.02889185869388585\ \(0\)\
\-\ soft\\:\\ 0\\.028619937942695312\ \(0\)\
\-\ into\\:\\ 0\\.028577149585792085\ \(0\)\
\-\ associated\\:\\ 0\\.0283348167853923\ \(0\)\
\-\ imaging\\:\\ 0\\.02825196685031682\ \(0\)\
\-\ tissue\\:\\ 0\\.028200553087126486\ \(0\)\
\-\ demonstrate\\:\\ 0\\.027947609309250835\ \(0\)\
\-\ present\\:\\ 0\\.02758528684885953\ \(0\)\
\-\ may\\:\\ 0\\.02705302573865543\ \(0\)\
\-\ case\\:\\ 0\\.027007739157427314\ \(0\)\
\-\ well\\:\\ 0\\.026030182109076948\ \(0\)\
\-\ lesion\\:\\ 0\\.02577307168573775\ \(0\)\
\-\ treatment\\:\\ 0\\.02560807663532208\ \(0\)\
\-\ within\\:\\ 0\\.024759556272550214\ \(0\)\
\-\ male\\:\\ 0\\.02393539946236783\ \(0\)\
\-\ that\\:\\ 0\\.023329219040590373\ \(0\)\
\-\ by\\:\\ 0\\.022829022033300155\ \(0\)\
\-\ normal\\:\\ 0\\.02194927842757127\ \(0\)\
\-\ an\\:\\ 0\\.02055711054105695\ \(0\)\
\-\ history\\:\\ 0\\.020538899676610364\ \(0\)\
\-\ was\\:\\ 0\\.0187354064807698\ \(0\)\
\-\ or\\:\\ 0\\.018701661835697724\ \(0\)\
\-\ this\\:\\ 0\\.018472425188658017\ \(0\)\
\-\ patient\\:\\ 0\\.017484975839680922\ \(0\)\
\-\ no\\:\\ 0\\.017481687017655363\ \(0\)\
\-\ year\\:\\ 0\\.01656734400098089\ \(0\)\
\-\ for\\:\\ 0\\.016293820946006326\ \(0\)\
\-\ on\\:\\ 0\\.01623602181102152\ \(0\)\
\-\ old\\:\\ 0\\.015910385169388877\ \(0\)\
